The results delineate increased expression of angiogenic and oncogenic markers CXCR4, SDF-1, and decreased expression of tumor suppressor genes, IRF1, LDOC1, and FOXO3 in CP patient tissues (Fig. 4A). The gene discussed is LDOC1; the disease is neoplasm.